MAP Goals for Hypertensive Patients on Nicardipine
For most hypertensive emergencies treated with nicardipine, target a 20-25% reduction in mean arterial pressure (MAP) over several hours, which typically translates to a MAP goal of <130 mmHg. 1
Context-Specific MAP Targets
The specific MAP goal depends critically on the underlying hypertensive emergency:
Standard Hypertensive Emergencies
- Target MAP reduction: 20-25% from baseline over several hours 1
- For malignant hypertension with or without thrombotic microangiopathy: MAP reduction of 20-25% over several hours 1
- For hypertensive encephalopathy: immediate MAP reduction of 20-25% 1
- In clinical practice, this typically means maintaining MAP <130 mmHg 2
Acute Stroke Syndromes
- Acute ischemic stroke with BP >220/120 mmHg: Target MAP reduction of 15% over 1 hour 1
- Acute ischemic stroke requiring thrombolysis (BP >185/110 mmHg): Target MAP reduction of 15% over 1 hour 1
- Acute hemorrhagic stroke with SBP >180 mmHg: Target systolic BP 130-180 mmHg (corresponding MAP approximately 90-120 mmHg) 1
Cardiac Emergencies
- Acute coronary syndrome: Target systolic BP <140 mmHg (MAP approximately <100 mmHg) 1
- Acute cardiogenic pulmonary edema: Target systolic BP <140 mmHg (MAP approximately <100 mmHg) 1
- Acute aortic dissection: Target systolic BP <120 mmHg and heart rate <60 bpm (MAP approximately <90 mmHg) - though nicardipine is typically used as alternative therapy here 1
Obstetric Emergencies
- Eclampsia/severe pre-eclampsia: Target systolic BP <160 mmHg and diastolic BP <105 mmHg (MAP approximately <120 mmHg) 1
Practical Dosing to Achieve MAP Goals
Nicardipine infusion should be initiated at 5 mg/hr and titrated by 2.5 mg increments every 15-30 minutes until the target MAP is achieved, with a typical maintenance dose of 3-8 mg/hr 1, 3
- Onset of action: 5-15 minutes 1
- Duration of action: 30-40 minutes 1
- Maximum dose: 15 mg/hr 1
- After achieving target MAP, reduce to maintenance dose (typically 3 mg/hr) 1
Critical Monitoring Considerations
Avoid excessive MAP reduction (>50% decrease) as this has been associated with ischemic stroke and death 1
- Monitor MAP continuously during titration 2
- In neurological emergencies, nicardipine effectively reduces MAP without adversely affecting cerebral tissue oxygenation, even when cerebral perfusion pressure decreases 4
- Nicardipine achieves target MAP goals in 86-91% of patients within 30 minutes to 77 minutes, depending on severity 2, 5
Common Pitfalls
- Do not use fixed MAP targets across all hypertensive emergencies - the underlying organ damage dictates the appropriate target 1
- Avoid rapid overcorrection - gradual reduction over hours (not minutes) is preferred for most conditions except aortic dissection and pulmonary edema 1
- In acute ischemic stroke, withhold treatment unless BP exceeds specific thresholds (>220/120 mmHg or >185/110 mmHg if thrombolysis planned) 1
- Expect reflex tachycardia (mean increase 7-8 bpm) as a normal physiologic response to vasodilation 3